QIF IV reaches final closing

8 April 2024  •  2 min
Quadrum QIF IV

[Almelo, April 5, 2024] – Quadrum Capital is proud to announce that its fourth fund – Quadrum Investment Fund IV (QIF IV) – has successfully been completed with an amount of approximately €400 million. In December 2021, QIF IV was launched with a target fund size of €350 million. This fund built on the success of its predecessor, QIF III, which reached final closing within six months due to strong interest from both individual and institutional investors.

The final closing of Quadrum Investment Fund IV (QIF IV) took place after successful fundraising. The fund now has a diverse and valuable group of more than 300 entrepreneurs and family offices, who are strongly involved and form a unique network of their own.

Strong portfolio

The QIF IV portfolio now consists of six platform companies, all in the focus sectors IT, Tech, Healthcare, Packaging and Human Capital. With an international orientation, this fund focused on mature, unlisted mid-market companies from The Netherlands and the Benelux with an ambition for international growth. This fund has been allocated and invested in companies, including LensOnline, Novature, Ventiv & Siebert and Wassink, The Trainee Company and SealteQ Group.

All companies have been selected due to the presence of highly qualified management teams, a strong market position, a distinctive offering and potential for strong autonomous or buy & build development. Quadrum Capital looks forward with confidence to the next phase of its growth and remains committed to supporting entrepreneurs and driving innovation.

With the successful closing of QIF IV, Quadrum Capital strengthens its position as a leading player in the private equity market and remains committed to stimulating entrepreneurship and growth in the region and beyond.

Investment company Quadrum Capital supports companies in the mid-market segment in realizing their growth ambitions. Quadrum distinguishes itself by a true entrepreneurial mentality, strong regional roots and a no-nonsense approach.

Terug naar overzicht